Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus

Journal of the American Heart Association

  ^{1    2    3    4    4    5    5    5    5    6    7    8} 

[1] CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands;Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands;Department of Genetics and Cell Biology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands;Department of Pediatrics, Molecular Genetics, University Medical Center Groningen, Groningen, The Netherlands;Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands;Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands;Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands;Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands;Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands;National Institute for Public Health and the Environment, Bilthoven, The Netherlands;National Institute for Public Health and the Environment, Bilthoven, The Netherlands;

关键词: biomarker;    cardiovascular disease prevention;    cardiovascular disease risk factors;    risk stratification;   

DOI  :  10.1161/JAHA.115.003048

来源: publisher

【 授权许可】

Unknown